TBX1 and neoplasm: Since the activation of CAFs in the TME is a vital factor leading to malignant progression of tumors, understanding the activation mechanism of CAFs in the TME may be a key measure to find effective intervention methods to block the activation of CAFs in the microenvironment and enhance the efficacy of tumor treatment.